These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 486308)

  • 21. ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.
    Bakowski MT
    Cancer Treat Rev; 1976 Jun; 3(2):95-107. PubMed ID: 821609
    [No Abstract]   [Full Text] [Related]  

  • 22. Combined effect of procarbazine and ionizing radiation on mouse jejunal crypts.
    Connor AM; Sigdestad CP
    Chemotherapy; 1978; 24(6):368-73. PubMed ID: 699678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicin.
    Giuliani F; Casazza AM; Di Marco A; Savi G
    Cancer Treat Rep; 1981; 65(3-4):267-76. PubMed ID: 6263470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lewis lung carcinoma lines with different metastatic behavior: response to ICRF-159.
    Zupi G; Cavallari A; Greco C; Sacchi A
    Anticancer Res; 1984; 4(1-2):91-5. PubMed ID: 6712181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumor.
    Heston WD; Kadmon D; Fair WR
    Cancer Lett; 1981 Jul; 13(2):139-45. PubMed ID: 7306951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of experimental lung metastases by cultured B16 melanoma cells treated with (+/-)-1,2-bis(3,5-dioxopiperazin-1-y)propane (ICRF-159).
    Lazo JS; Ingber DE; Sartorelli AC
    Cancer Res; 1978 Aug; 38(8):2263-70. PubMed ID: 667822
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of ICRF 159 and trition WR 1339 on metastases of a rat epithelioma.
    Pimm MV; Baldwin RW
    Br J Cancer; 1975 Jan; 31(1):62-7. PubMed ID: 1156509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa.
    Mason KA; Milas L; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1381-9. PubMed ID: 7635778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereoselective effects of cis- and trans-cyclopropylbis (dioxopiperazines) related to ICRF-159 on metastases of hamster lung adenocarcinoma.
    Witiak DT; Lee HJ; Goldman HD; Zwilling BS
    J Med Chem; 1978 Dec; 21(12):1194-7. PubMed ID: 722727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy and ICRF 159 in the treatment of soft tissue sarcomas.
    Ryall RD
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):133-4. PubMed ID: 632140
    [No Abstract]   [Full Text] [Related]  

  • 31. Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer.
    Speyer JL; Green MD; Kramer E; Rey M; Sanger J; Ward C; Dubin N; Ferrans V; Stecy P; Zeleniuch-Jacquotte A
    N Engl J Med; 1988 Sep; 319(12):745-52. PubMed ID: 3137469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer.
    Bakowski MT; Macdonald E; Mould RF; Cawte P; Sloggem J; Barrett A; Dalley V; Newton KA; Westbury G; James SE; Hellmann K
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):115-9. PubMed ID: 344287
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radio-oncological treatment possibilities in local recurrence of rectal carcinoma. An interdisciplinary comparison].
    Rhomberg W; Eiter H
    Wien Med Wochenschr; 1990 Apr; 140(8):206-11. PubMed ID: 2194376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiosensitization of pulmonary metastases-I. In vivo testing of hycanthone, insulin and razoxane.
    Davies BM; Watling DC
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):803-9. PubMed ID: 500411
    [No Abstract]   [Full Text] [Related]  

  • 35. Biological properties of ICRF-159 and related bis(dioxopiperazine) compounds.
    Herman EH; Witiak DT; Hellmann K; Waravdekar VS
    Adv Pharmacol Chemother; 1982; 19():249-90. PubMed ID: 6819768
    [No Abstract]   [Full Text] [Related]  

  • 36. Pretreatment with ICRF-187 provides long-lasting protection against chronic daunorubicin cardiotoxicity in rabbits.
    Herman EH; Ferrans VJ
    Cancer Chemother Pharmacol; 1986; 16(2):102-6. PubMed ID: 3081268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interference with in vivo growth and metastasis of prostate adenocarcinoma (PA-III) by ICRF-159.
    Pollard M; Burleson GR; Luckert PH
    Prostate; 1981; 2(1):1-9. PubMed ID: 7279810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
    Holm B; Sehested M; Jensen PB
    Clin Cancer Res; 1998 Jun; 4(6):1367-73. PubMed ID: 9626452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A trial of razoxane (ICRF-159) in patients with prior therapy for Hodgkin's lymphoma.
    Corder MP; McFadden DB; Bell SJ
    Cancer; 1984 Oct; 54(8):1496-8. PubMed ID: 6383594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of adriamycin and adriamycin-radiation combination on jejunal proliferation in the mouse.
    Burholt DR; Hagemann RF; Schenken LL; Lesher S
    Cancer Res; 1977 Jan; 37(1):22-7. PubMed ID: 830408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.